Skip to product information
1 of 1

Cloud-clone

SKU:RPS366Hu02

Recombinant Filaggrin 2 (FLG2)

Recombinant Filaggrin 2 (FLG2)

Regular price $450.00 USD
Regular price Sale price $450.00 USD
Sale Sold out
Shipping calculated at checkout.
UOM
Purity
Organism species

Prokaryotic expression

Product No.

RPS366Hu02

Organism Species

Homo sapiens (Human).

Source

Prokaryotic expression

Host

E.coli

Endotoxin Level

<1.0EU per 1µg (determined by the LAL method)

Subcellular Location

Secreted

Predicted Molecular Mass

17.4kDa

Accurate Molecular Mass

21kDa(Analysis of differences refer to the manual)

Residues & Tags

Glu1222~Gln1368 with N-terminal His Tag

Buffer Formulation

PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.

Traits

Freeze-dried powder

Purity

> 90%

Isoelectric Point

11.1

Applications

Positive Control; Immunogen; SDS-PAGE; WB.

If bio-activity of the protein is needed, please check active protein.

UOM

10µg 50µg 200µg 1mg 5mg

 

SEQUENCE

 

 

 

USAGE

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPS366Hu01 Recombinant Filaggrin 2 (FLG2) Positive Control; Immunogen; SDS-PAGE; WB.
RPS366Hu02 Recombinant Filaggrin 2 (FLG2) Positive Control; Immunogen; SDS-PAGE; WB.
PAS366Hu01 Polyclonal Antibody to Filaggrin 2 (FLG2) WB; IHC; ICC; IP.
PAS366Hu02 Polyclonal Antibody to Filaggrin 2 (FLG2) WB; IHC; ICC; IP.
LAS366Hu71 Biotin-Linked Polyclonal Antibody to Filaggrin 2 (FLG2) WB; IHC; ICC.
View full details